Skip to main content

Advertisement

SpringerLink
Log in

The diagnostic value of serum DSA-TRF in hepatocellular carcinoma

  • Original Article
  • Published:
Glycoconjugate Journal Aims and scope Submit manuscript

Abstract

TRF is a glycoprotein mainly secreted by hepatocytes, The aim of this study was to explore the diagnostic value of aberrant glycosylated serum transferrin (TRF) especially containing multi-antennary glycans in hepatocellular carcinoma (HCC).A total of 581 subjects including HCC patients, liver cirrhosis (LC) patients, chronic hepatitis (CHB) patients and healthy controls (HC) were recruited. All the subjects were randomly assigned to training group (n = 411) and validation group (n = 170). We firstly analyzed the serum protein N-glycome profiling of HCC, LC, and HC by DNA sequencer–assisted fluorophore-assisted carbohydrate electrophoresis (DSA-FACE) technology. We established a lectin-antibody sandwich ELISA (Lectin-ELISA) method to detect multi-antennary glycans-contained TRF (DSA-TRF) in serum, in which Datura stramonium Agglutinin (DSA) was used for specific recognition. Levels of serum DSA-TRF and TRF were analyzed respectively. The diagnostic efficacies of DSA-TRF and TRF of differentiating HCC patients from CHB, LC patients and HC within the training group were evaluated using receiver operating characteristic (ROC) curve and tested in the validation group.The result found that in training group, serum TRF and DSA-TRF levels differed significantly between HCC (1.86 ± 0.50, g/L, 0.285 ± 0.06), CHB + LC (2.39 ± 0.74, g/L, 0.189 ± 0.07) and HC (1.92 ± 0.69, g/L, 0.249 ± 0.09) (HCC vs. CHB + LC, P < 0.001; HCC vs. HC, P < 0.001; CHB + LC vs. HC, P < 0.001). The area under the ROC curve (AUC) of DSA-TRF was significantly superior to AFP (0.880, 95%CI: 0.834–0.925 vs. 0.776, 95%CI: 0.725–0.827, P = 0.003) in differentiating HCC from CHB + LC. The AUC of diagnostic model GlycoTRF1 (0.981, 95%CI: 0.969–0.993) was higher than DSA-TRF and AFP alone (P<0.001) in differentiating HCC from CHB + LC, which was verified in validation group.The results indicated that the serum DSA-TRF might serve as a potential glycan biomarker for distinguishing HCC from CHB and LC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Clerc, F., Reiding, K.R., Jansen, B.C., Kammeijer, G.S., Bondt, A., Wuhrer, M.: Human plasma protein N-glycosylation. Glycoconj. J. 33(3), 309–343 (2016)

    Article  CAS  Google Scholar 

  2. Wang, M., Zhu, J., Lubman, D.M., Gao, C.: Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey. Clin. Chem. Lab. Med. 57(4), 407–416 (2019)

    Article  Google Scholar 

  3. Drabik, A.: Glycopeptides as a Tool for Early Detection of Cancer. Proteomics Clin. Appl. 12(6), e1800108 (2018)

    Article  Google Scholar 

  4. Wang, F.S., Fan, J.G., Zhang, Z., Gao, B., Wang, H.Y.: The global burden of liver disease: the major impact of China. Hepatology. 60(6), 2099–2108 (2014)

    Article  Google Scholar 

  5. Mehta, A., Herrera, H., Block, T.: Glycosylation and liver cancer. Adv. Cancer Res. 126, 257–279 (2015)

    Article  CAS  Google Scholar 

  6. Ko, Y.S., Bae, J.H., Sinn, D.H., Gwak, G.Y., Kang, W., Paik, Y.H., Choi, M.S., Lee, J.H., Koh, K.C., Paik, S.W.: The Clinical Significance of Serum Alpha-fetoprotein in Diagnosing Hepatocellular Carcinoma in a Health Screening Population. Korean J Gastroenterol. 69(4), 232–238 (2017)

    Article  Google Scholar 

  7. Mathew, S., Ali, A., Abdel-Hafiz, H., Fatima, K., Suhail, M., Archunan, G., Begum, N., Jahangir, S., Ilyas, M., Chaudhary, A.G., Al, Q.M., Mohamad, B.S., Qadri, I.: Biomarkers for virus-induced hepatocellular carcinoma (HCC). Infect. Genet. Evol. 26, 327–339 (2014)

    Article  CAS  Google Scholar 

  8. Cheng, J., Wang, W., Zhang, Y., Liu, X., Li, M., Wu, Z., Liu, Z., Lv, Y., Wang, B.: Prognostic role of pre-treatment serum AFP-L3% in hepatocellular carcinoma: systematic review and meta-analysis. PLoS One. 9(1), e87011 (2014)

    Article  Google Scholar 

  9. Leerapun, A., Suravarapu, S.V., Bida, J.P., Clark, R.J., Sanders, E.L., Mettler, T.A., Stadheim, L.M., Aderca, I., Moser, C.D., Nagorney, D.M., LaRusso, N.F., de Groen, P.C., Menon, K.V., Lazaridis, K.N., Gores, G.J., Charlton, M.R., Roberts, R.O., Therneau, T.M., Katzmann, J.A., Roberts, L.R.: The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population. Clin. Gastroenterol. Hepatol. 5(3), 394–402, 267 (2007)

    Article  CAS  Google Scholar 

  10. Barle, H., Nyberg, B., Essen, P., Andersson, K., McNurlan, M.A., Wernerman, J., Garlick, P.J.: The synthesis rates of total liver protein and plasma albumin determined simultaneously in vivo in humans. Hepatology. 25(1), 154–158 (1997)

    CAS  PubMed  Google Scholar 

  11. Zhu, J., Lin, Z., Wu, J., Yin, H., Dai, J., Feng, Z., Marrero, J., Lubman, D.M.: Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies. J. Proteome Res. 13(6), 2986–2997 (2014)

    Article  CAS  Google Scholar 

  12. Comunale, M.A., Wang, M., Anbarasan, N., Betesh, L., Karabudak, A., Moritz, E., Devarajan, K., Marrero, J., Block, T.M., Mehta, A.: Total serum glycan analysis is superior to lectin-FLISA for the early detection of hepatocellular carcinoma. Proteomics Clin. Appl. 7(9–10), 690–700 (2013)

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Comunale, M.A., Lowman, M., Long, R.E., Krakover, J., Philip, R., Seeholzer, S., Evans, A.A., Hann, H.W., Block, T.M., Mehta, A.S.: Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J. Proteome Res. 5(2), 308–315 (2006)

    Article  CAS  Google Scholar 

  14. Miyahara, K., Nouso, K., Dohi, C., Morimoto, Y., Kinugasa, H., Wada, N., Takeuchi, Y., Kuwaki, K., Onishi, H., Ikeda, F., Miyake, Y., Nakamura, S., Shiraha, H., Takaki, A., Amano, M., Nishimura, S.I., Yamamoto, K.: Alteration of N-glycan profiles in patients with chronic hepatitis and hepatocellular carcinoma. Hepatol. Res. 45(9), 986–993 (2015)

    Article  CAS  Google Scholar 

  15. Parkkinen, J., von Bonsdorff, L., Ebeling, F., Sahlstedt, L.: Function and therapeutic development of apotransferrin. Vox Sang. 83(Suppl 1), 321–326 (2002)

    Article  CAS  Google Scholar 

  16. Gomme, P.T., McCann, K.B., Bertolini, J.: Transferrin: structure, function and potential therapeutic actions. Drug Discov. Today. 10(4), 267–273 (2005)

    Article  CAS  Google Scholar 

  17. Yamashita, K., Koide, N., Endo, T., Iwaki, Y., Kobata, A.: Altered glycosylation of serum transferrin of patients with hepatocellular carcinoma. J. Biol. Chem. 264(5), 2415–2423 (1989)

    CAS  PubMed  Google Scholar 

  18. Matsumoto, K., Maeda, Y., Kato, S., Yuki, H.: Alteration of asparagine-linked glycosylation in serum transferrin of patients with hepatocellular carcinoma. Clin. Chim. Acta. 224(1), 1–8 (1994)

    Article  CAS  Google Scholar 

  19. Liu, X.E., Desmyter, L., Gao, C.F., Laroy, W., Dewaele, S., Vanhooren, V., Wang, L., Zhuang, H., Callewaert, N., Libert, C., Contreras, R., Chen, C.: N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus. Hepatology. 46(5), 1426–1435 (2007)

    Article  CAS  Google Scholar 

  20. Li, L., Gu, X., Fang, M., Ji, J., Yi, C., Gao, C.: The diagnostic value of serum fucosylated fetuin A in hepatitis B virus-related liver diseases. Clin. Chem. Lab. Med. 54(4), 693–701 (2016)

    Article  CAS  Google Scholar 

  21. DeLong, E.R., DeLong, D.M., Clarke-Pearson, D.L.: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 44(3), 837–845 (1988)

    Article  CAS  Google Scholar 

  22. Fang, M., Zhao, Y.P., Zhou, F.G., Lu, L.G., Qi, P., Wang, H., Zhou, K., Sun, S.H., Chen, C.Y., Gao, C.F.: N-glycan based models improve diagnostic efficacies in hepatitis B virus-related hepatocellular carcinoma. Int. J. Cancer. 127(1), 148–159 (2010)

    Article  CAS  Google Scholar 

  23. Telford, J.E., Doherty, M.A., Tharmalingam, T., Rudd, P.M.: Discovering new clinical markers in the field of glycomics. Biochem. Soc. Trans. 39(1), 327–330 (2011)

    Article  CAS  Google Scholar 

  24. El-Aneed, A., Banoub, J.: Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients. Anticancer Res. 26(5A), 3293–3300 (2006)

    CAS  PubMed  Google Scholar 

  25. Cui, Y., Jia, J.: Update on epidemiology of hepatitis B and C in China. J. Gastroenterol. Hepatol. 28(Suppl 1), 7–10 (2013)

    Article  Google Scholar 

  26. Haab, B.B.: Antibody-lectin sandwich arrays for biomarker and glycobiology studies. Expert Rev Proteomics. 7(1), 9–11 (2010)

    Article  CAS  Google Scholar 

  27. Shimomura, M., Nakayama, K., Azuma, K., Terao, N., Nishino, K., Takamatsu, S., Nakano, M., Takahashi, S., Kobayashi, Y., Murata, K., Kamada, Y., Miyoshi, E.: Establishment of a novel lectin-antibody ELISA system to determine core-fucosylated haptoglobin. Clin. Chim. Acta. 446, 30–36 (2015)

    Article  CAS  Google Scholar 

  28. Matsumoto, H., Shinzaki, S., Narisada, M., Kawamoto, S., Kuwamoto, K., Moriwaki, K., Kanke, F., Satomura, S., Kumada, T., Miyoshi, E.: Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer. Clin. Chem. Lab. Med. 48(4), 505–512 (2010)

    Article  CAS  Google Scholar 

  29. Wei, X., Li, N., Li, S., Shi, J., Guo, W., Zheng, Y., Cheng, S.: Hepatitis B virus infection and active replication promote the formation of vascular invasion in hepatocellular carcinoma. BMC Cancer. 17(1), 304 (2017)

    Article  Google Scholar 

Download references

Acknowledgements

This study was funded by the National Science and Technology Major Project of China (2018ZX10302205-003) and the Science and Technology Commission of Shanghai Municipality(17JC1404500, 17411960500, 15JC1404100).

Author information

Author notes

  1. Wenqian Guan and Zhiyuan Gao contributed equally to this work.

Authors and Affiliations

  1. Department of Laboratory Medicine, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, People’s Republic of China

    Wenqian Guan, Zhiyuan Gao, Chenjun Huang, Meng Fang, Huijuan Feng, Shipeng Chen, Mengmeng Wang, Jun Zhou, Song Hong & Chunfang Gao

  2. Clinical Medical College, Fujian Medical University, Fuzhou, People’s Republic of China

    Wenqian Guan & Chenjun Huang

  3. Department of Emergency Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, People’s Republic of China

    Mengmeng Wang

Authors
  1. Wenqian Guan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhiyuan Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chenjun Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Meng Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Huijuan Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shipeng Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mengmeng Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jun Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Song Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Chunfang Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chunfang Gao.

Ethics declarations

Conflict of interest

The authors declare that there are no conflicts of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guan, W., Gao, Z., Huang, C. et al. The diagnostic value of serum DSA-TRF in hepatocellular carcinoma. Glycoconj J 37, 231–240 (2020). https://doi.org/10.1007/s10719-019-09906-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10719-019-09906-x

Keywords

Search

Navigation